Christopher M. Jones, PharmD, MPH

Director | National Mental Health and Substance Abuse Policy Laboratory

Christopher M. Jones, PharmD, MPH

Director | National Mental Health and Substance Abuse Policy Laboratory

Biography

Christopher M. Jones currently serves as the Director of the National Mental Health and Substance Use Policy Laboratory at the Substance Abuse and Mental Health Services Administration (SAMHSA).

Prior to joining SAMHSA, Dr. Jones served as Acting Associate Deputy Assistant Secretary for Science and Data Policy and Director of the Division of Science Policy in the Office of the Assistant Secretary for Planning and Evaluation (ASPE) at the U.S. Department of Health and Human Services. The Office of Science and Data Policy is the HHS focal point for policy research, analysis, evaluation, and coordination of public health, science, and data policy activities, and provides authoritative advice and analytical support to HHS leadership on public health, science, and data policy issues and initiatives. He has also served as senior advisor in the Office of the Commissioner at the U.S. Food and Drug Administration (FDA) and led the Centers for Disease Control and Prevention’s (CDC) drug abuse and overdose activities where he focused on strategic policy development and implementation, engaging national and state partners, and conducting research to improve policy and clinical practice. During his career, Dr. Jones has served as Senior Public Health Advisor to the White House Office of National Drug Control Policy, led the FDA’s Drug Safety and Risk Communication team, and served on the Science Team in the CDC’s Strategic National Stockpile. He received his Bachelor of Science degree from Reinhart College, his Doctor of Pharmacy degree from Mercer University, his Master of Public Health degree from New York Medical College, and is currently completing his Doctorate of Public Health in Heath Policy at The George Washington University Milken Institute School of Public Health. Dr. Jones has authored more than 50 peer-reviewed publications on the topic of drug abuse and overdose.

All session by Christopher M. Jones, PharmD, MPH

Opening Plenary

8:00 am-9:00 am
Columbia AB